Cresset Expands Sales Pipeline Potential through CambridgeSoft Alliance
News Apr 20, 2009
Cresset Biomolecular Discovery Ltd (Cresset), announces that their recent distribution agreement with CambridgeSoft© Corporation has led to an increase in the company’s sales pipeline.
Under the terms of the agreement, CambridgeSoft sells Cresset’s FieldAlign and FieldTemplater products using its direct, telesales and ecommerce channels. FieldAlign and FieldTemplater are designed for both molecular modellers and medicinal chemists who want to discover new drugs against a wide range of biological targets. The products enable scientists to determine important interactions between ligands and proteins and to efficiently prioritize compounds for biological evaluation.
“I believe that this partnership will enable Cresset to increase sales of FieldAlign and FieldTemplater this year. The interest that Cambridgesoft has generated in our products is very encouraging, and I look forward to more organisations using these tools to develop new medicines” said Bea Leigh, CEO, Cresset BioMolecular Discovery.
“We are excited to be able to provide Cresset’s innovative solutions to our established customer base,” said Michael G. Tomasic, President and Chief Executive Officer of CambridgeSoft. “By delivering FieldAlign and FieldTemplater to CambridgeSoft customers through established business channels, we will extend the reach of these valuable tools to a wider audience of scientists, and help them apply field technology to hit-finding, lead-switching, IP scanning, and portfolio management.”
Cresset is leveraging CambridgeSoft’s established sales and marketing infrastructure to enable their inspiring products to reach a larger chemistry market. The initial CambridgeSoft campaigns promoting Cresset’s free one month evaluation of FieldAlign and FieldTemplater software have been successful. Through a link in CambridgeSoft’s online Scistore.com, Cresset has seen the number of trial downloads increase 10 fold over the previous quarter swelling their sales pipeline.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018